[The assessment of therapeutic success in chronic myeloid leukemia].
Griesshammer
M
M
Abteilung Innere Medizin III, Universität Heidelberg.
Hehlmann
R
R
Heimpel
H
H
D016026:Bone Marrow Transplantation; D002066:Busulfan / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D016898:Interferon-alpha / Q000627:therapeutic use; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000097:blood / Q000235:genetics / Q000628:therapy*; D054438:Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / Q000628:therapy; D010166:Palliative Care; D012074:Remission Induction
D016898:Interferon-alpha; D002066:Busulfan; D006918:Hydroxyurea